5-Bromo-2-isobutoxypyridine

Catalog No.: 
ACRTYB318
CAS No.: 
1251385-87-1
Molecular Formula: 
C9H12BrNO
Molecular Weight: 
230.10
5-Bromo-2-isobutoxypyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$370.00InquiryInquiry
250mg95%$565.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-isobutoxypyridine
IUPAC Name5-bromo-2-isobutoxypyridine
MDL No.MFCD14652089
Molecular FormulaC9H12BrNO
Molecular Weight230.10
SMILESCC(C)COC1=NC=C(Br)C=C1
InChI KeyPEGNKNXWZBYWOA-UHFFFAOYSA-N
Synonym5-bromo-2-(2-methylpropoxy)Pyridine;5-Bromo-2-isobutoxypyridine;Pyridine, 5-bromo-2-(2-methylpropoxy)-
CAS No.1251385-87-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRTYB318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIWBF532 route compound structure diagram
    ACIWBF532766-11-0In Stock
  4. Then
  5. ACRTYB318 route product structure diagram
    ACRTYB3181251385-87-1
Inquiry

2. ACRTYB318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKWO017 route compound structure diagram
    ACCKWO017624-28-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTYB318 route product structure diagram
    ACRTYB3181251385-87-1
Inquiry

3. ACRTYB318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYIHU365 route compound structure diagram
    ACYIHU36553939-30-3In Stock
  4. Then
  5. ACRTYB318 route product structure diagram
    ACRTYB3181251385-87-1
Inquiry

Comments (0)